Advertisement Arno Therapeutics names new CFO - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Arno Therapeutics names new CFO

US-based clinical-stage biopharmaceutical company Arno Therapeutics has appointed Brian Lenz as its new CFO.

Mr Lenz brings over 10 years of financial and operational management experience in addition to significant experience in capital raising and mergers and acquisition activities.

Prior to joining Arno Therapeutics, Mr Lenz was CFO and treasurer of VioQuest Pharmaceuticals since 2004, and prior to that served as the company’s controller from 2003 to 2004.

Mr Lenz holds a BS in accounting from Rider University and received his MBA from Saint Joseph’s University. He is a certified public accountant licensed in the State of New Jersey.

Scott Fields, president and chief medical officer of Arno, said: “We are very pleased to have someone with Brian’s broad financial and public markets experience join our team. We look forward to working with him as we continue to grow and expand our operations.”